Relative Strength Chart Intellia Therapeutics, Inc.
Equities
NTLA
US45826J1051
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.83 USD | -0.29% |
|
+5.33% | +53.84% |
| Mar. 06 | Nektar Therapeutics reports inducement grants under Nasdaq Listing Rule 5635(c)(4) | RE |
| Mar. 03 | Intellia Therapeutics Presents Longer-Term Clinical Data For Lonvoguran Ziclumeran | CI |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -0.29% | +5.33% | +53.84% | +95.34% | -80.42% | 1.63B |  | | |
- Stock Market
- Equities
- NTLA Stock
- Charts Intellia Therapeutics, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
